Evidence map›Paper›PMID 34900934›Full record

ArticleFrontiers in chemistry2021

Antibacterial Properties and Mechanism of Lysozyme-Modified ZnO Nanoparticles.

Kangrui Yuan, Xiaoliu Liu, Jianxin Shi, Wei Liu, Kun Liu, Hongmei Lu, Dudu Wu, Zhi Chen, Chengyu Lu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kangrui YuanSchool of Pharmacy, Guangdong Medical University, Dongguan, China.
Xiaoliu LiuMedical Laboratory of Shenzhen Luohu People's Hospital, Shenzhen, China.
Jianxin ShiSchool of Pharmacy, Guangdong Medical University, Dongguan, China.
Wei LiuSchool of Pharmacy, Guangdong Medical University, Dongguan, China.
Kun LiuSchool of Pharmacy, Guangdong Medical University, Dongguan, China.
Hongmei LuThe First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
Dudu WuSchool of Pharmacy, Guangdong Medical University, Dongguan, China.
Zhi ChenSchool of Pharmacy, Guangdong Medical University, Dongguan, China.
Chengyu LuSchool of Pharmacy, Guangdong Medical University, Dongguan, China.
Guangdong Medical College · CNDongguan People’s Hospital · CNShenzhen Luohu People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lysozyme-modified nanoparticles (LY@ZnO NPs) were synthesized by the reduction-oxidation method, and the morphology and structure of LY@ZnO were analyzed by Fourier transform infrared (FTIR) spectroscopy, powder X-ray diffraction (XRD), scanning electron microsclope (SEM), and particle size analysis. The antibacterial effects of LY@ZnO against

Indexed as

antibacterial activityenzymelysozymenanomaterialsZnO nanoparticles

Identifiers

PMID34900934
PMCPMC8660975
OpenAlexW3216851907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.